is oral glp 1 effective FDA Approves Semaglutide as the First Oral GLP-1 Pill GLP-1 Pills vs. Injections: Weight

Acknowledgments The figure was constructed using BioRender.com (accessed on 21 December 2023)

Pfizer, which is developing an oral GLP-1, estimates the total market could approach $100 billion in less than a decade, bigger than any other drug market and nine times Major League Baseballs annual revenue

Thus, AI and ML have immense potential to revolutionize the market

There aren't many head-to-head studies yet, but cross-study comparisons show that triple agonism may help people lose more weight

Consequently, choosing anti-hyperglycemic therapies with proven cardiovascular and renal benefits is now a cornerstone of T2DM management [2]

Renal Effects of DPP-4 Inhibitor Sitagliptin or GLP-1 Receptor Agonist Liraglutide in Overweight Patients With Type 2 Diabetes: A 12-Week, Randomized, Double-Blind, Placebo-Controlled Trial